US Stock MarketDetailed Quotes
KZIA Kazia Therapeutics
- 5.710
- +0.630+12.40%
Close Nov 19 16:00 ET
- 5.350
- -0.360-6.30%
Post 20:01 ET
19.01MMarket Cap-863P/E (TTM)
5.870High5.002Low72.95KVolume5.050Open5.080Pre Close403.95KTurnover2.30%Turnover RatioLossP/E (Static)3.33MShares15.80052wk High-2.92P/B18.10MFloat Cap1.86652wk Low--Dividend TTM3.17MShs Float158.500Historical High--Div YieldTTM17.09%Amplitude1.860Historical Low5.537Avg Price1Lot Size
Kazia Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q2)Dec 31, 2021 | (Q1)Sep 30, 2021 | (FY)Jun 30, 2021 | (Q2)Dec 31, 2020 | (Q1)Sep 30, 2020 | (FY)Jun 30, 2020 | (Q4)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 36.78%-9.58M | 33.42%-15.16M | -149.83%-22.76M | -3.42%-9.11M | -31.22%-8.81M | |||||
| Net income from continuing operations | -30.85%-26.78M | 18.19%-20.47M | -197.08%-25.01M | ---- | ---- | 32.46%-8.42M | ---- | ---- | -21.39%-12.47M | ---- |
| Operating gains losses | -143.48%-20K | 102.14%46K | -603.27%-2.15M | ---- | ---- | --428K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 0.00%1.87M | 0.00%1.87M | 47.75%1.87M | ---- | ---- | 16.70%1.27M | ---- | ---- | 0.00%1.08M | ---- |
| Other non cash items | 390.65%6.1M | ---2.1M | ---- | ---- | ---- | 442.19%2.57M | ---- | ---- | 652.38%474K | ---- |
| Change In working capital | 130.89%10M | 402.55%4.33M | 115.42%862K | ---- | ---- | -434.99%-5.59M | ---- | ---- | 372.80%1.67M | ---- |
| -Change in receivables | -99.86%5K | 49,385.71%3.45M | 99.86%-7K | ---- | ---- | -1,504.19%-5.03M | ---- | ---- | -47.89%358K | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | -603.57%-1.18M | ---- | ---- | -142.21%-168K | ---- |
| -Change in payables and accrued expense | 1,787.17%10.74M | 207.77%569K | -152.28%-528K | ---- | ---- | -41.35%1.01M | ---- | ---- | 521.03%1.72M | ---- |
| -Change in other current assets | 185.21%1.04M | 231.77%365K | ---277K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | -2,482.22%-1.16M | -102.44%-45K | --1.84M | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in other working capital | -8,757.14%-620K | 95.81%-7K | 57.40%-167K | ---- | ---- | -61.32%-392K | ---- | ---- | 24.77%-243K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 36.78%-9.58M | 33.42%-15.16M | -149.83%-22.76M | ---- | ---- | -3.42%-9.11M | ---- | ---- | -31.22%-8.81M | ---- |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -2.37M | -278 | -1.58M | 0 | 0 | |||
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---1.58M | ---- | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | ---2.37M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---2.37M | ---278 | ---1.58M | --0 | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -53.86%5.99M | 248.15%12.97M | -86.74%3.73M | 131.56%28.11M | 23.6M | 12K | 218.11%12.14M | 8.4M | ||
| Net issuance payments of debt | --405K | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | -56.98%5.58M | 248.15%12.97M | -86.74%3.73M | ---- | ---- | 131.56%28.11M | --23.6M | --12K | 218.11%12.14M | --8.97M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---572K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -53.86%5.99M | 248.15%12.97M | -86.74%3.73M | -99.93%16.7K | --0 | 131.56%28.11M | --23.6M | --12K | 218.11%12.14M | --8.4M |
| Net cash flow | ||||||||||
| Beginning cash position | -28.80%5.24M | -73.32%7.36M | 214.78%27.59M | 199.92%19.62M | 214.78%27.59M | 61.28%8.76M | --6.54M | --8.76M | -8.76%5.43M | --3.11M |
| Current changes in cash | -64.65%-3.6M | 89.79%-2.18M | -212.65%-21.4M | -131.41%-4.26M | -291.63%-8.7M | 470.51%19M | --13.56M | ---2.22M | 717.81%3.33M | --5.65M |
| Effect of exchange rate changes | -81.25%12K | -94.55%64K | 771.43%1.18M | ---175.82K | --735K | ---175K | ---- | ---- | --0 | ---- |
| End cash Position | -68.38%1.66M | -28.80%5.24M | -73.32%7.36M | -21.57%15.19M | 199.92%19.62M | 214.78%27.59M | --19.37M | --6.54M | 61.28%8.76M | --8.76M |
| Free cash flow | 36.78%-9.58M | 33.42%-15.16M | -149.83%-22.76M | 73.16%-2.69M | -289.52%-8.7M | -3.42%-9.11M | ---10.04M | ---2.23M | -31.22%-8.81M | ---2.75M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
